Promising Genomics & Synthetic Biology Stocks to Consider in 2025 [Yahoo! Finance]
Wave Life Sciences Ltd. (NASDAQ: WVE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531 [Yahoo! Finance]
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
Wave Life Sciences Ltd. (NASDAQ: WVE) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.